Recent News

January 07, 2019

Survey reveals need for greater focus on sleep health

A recent survey by the AAHS shows that people who have sleep disorders desire convenient access to affordable care and accurate information.
January 07, 2019

RLS treatment option discontinued

The FDA recently indicated that ropinirole hydrochloride (Requip) and 2 mg dosages of extended release Requip XL will be discontinued by GlaxoSmithKline.
December 03, 2018

American Alliance for Healthy Sleep (AAHS) Partners with the Nocturia Council

The American Alliance of Healthy Sleep is collaborating with several other patient advocacy groups to form the Nocturia Council. The council is to bring awareness to the condition Nocturia, a treatable condition that forces individuals to wake multiple times at night to urinate....